
Topic
Radiation Segmentectomy
16 Podcasts • 14 Cases • 3 Courses on BackTable
Hear how experienced physicians approach Radiation Segmentectomy on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Episode # 659 • 30 Jun 2026
Combination Therapy for Hepatocellular Carcinoma
How do you safely combine locoregional and systemic therapies to treat hepatocellular carcinoma (HCC) when traditional guidelines suggest your hands are tied? In this episode of the 2026 HCC Creator Weekend™, medical oncologist Dr. Lingling Du (Ochsner Health) and interventional radiologist Dr. Beau Toskich (Mayo Clinic Florida) join Dr. Tyler Sandow to break down patient selection, timing strategies, and the practical application of clinical trial outcomes when integrating Y90 radioembolization and immunotherapy in HCC management.
This podcast is supported by an educational grant from Sirtex and Boston Scientific.
More on Radiation Segmentectomy
Loading recent podcasts…
Vascular & IR # 659
Jun 30, 2026
with Dr. Beau Toskich, Dr. Lingling Du, Dr. Tyler Sandow
How do you safely combine locoregional and systemic therapies to treat hepatocellular carcinoma (HCC) when traditional...
670+ listens
Vascular & IR # 653
Jun 9, 2026
with Dr. Beau Toskich, Dr. Christopher Malone, Dr. Venkatesh Krishnasamy
How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases?...
1,300+ listens
Vascular & IR # 649
May 27, 2026
with Dr. Nima Kokabi, Dr. Riad Salem, Dr. Zach Berman
Can the right dosimetry approach turn palliative Y90 into a curative therapy? In this episode of the BackTable 2026 HCC...
1,300+ listens
Vascular & IR # 642
May 7, 2026
with Dr. Beau Toskich, Dr. Zach Berman, Dr. Venkatesh Krishnasamy
Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is...
70+ listens
Vascular & IR # 655
Jun 16, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone, Dr. Zach Berman
How is Y90 radioembolization rewriting the rules for managing large HCC tumors and creating new curative-intent...
1,300+ listens
Vascular & IR # 651
Jun 2, 2026
with Dr. Kirema Garcia-Reyes, Dr. Zach Berman, Dr. Nima Kokabi
What does it really take to run a high-volume Y90 program that is efficient, scalable, and patient-centered? In this...
1,300+ listens
Vascular & IR # 644
May 12, 2026
with Dr. Neil Mehta, Dr. Ari Cohen, Dr. Venkatesh Krishnasamy
A high-functioning HCC tumor board can turn complex transplant decisions into coordinated treatment plans that account...
1,100+ listens
Vascular & IR # 561
Jul 29, 2025
with Dr. Tyler Sandow, Dr. Zach Berman, Dr. Venkatesh Krishnasamy
When is Y90 the right treatment for metastatic disease? Join Drs. Tyler Sandow, Zach Berman and host Kavi Krishnasamy...
2,100+ listens
VI Case
Jun 16, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 16, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jul 22, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
VI Case
Jul 22, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
VI Case
Jun 16, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 16, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jul 22, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
VI Case
Jul 22, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.




